ZNL-17230-96677
4 vaccinations
6 coded responses
26 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 496 / MI
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Pfizer-BioNTech
- 2020-12-28
-
2020-12-29
Survey response — days 1–6 daily, dose 1MedDRA: Arthralgia, Night sweats — Feeling: Good · Site: Pain · Chills, Muscle or body achesFree text: Shoulder joint pain, night sweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-30
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Fair · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Abdominal painFree text: Symptoms began 29 hours after injection. Felt fine by 32 hoursMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-31
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-11
-
2021-01-18
Dose 2 — Pfizer-BioNTech
- 2021-02-01
- 2021-03-01
-
2021-04-21
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: PoorFree text: Mild head cold. Runny nose, congestion, etc.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-19
Survey response — 6 months, dose 2MedDRA: Nausea, Pregnancy — Feeling: GoodFree text: Pregnant, estimated due date of 1/16/22. 14 weeks at time of survey. Uneventful pregnancy thus far apart from severe nausea.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-26
Dose 3 — Pfizer-BioNTech
-
2022-01-20
Survey response — 12 months, dose 2MedDRA: Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · HospitalizationFree text: Gave birth to healthy baby girl on (b)(6)MedDRA releases: 2024-11 · check-in free text available
-
2022-01-20
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-01-21
-
2022-10-26
Dose 4 — Pfizer-BioNTech
-
2022-10-26
Health check-in — day 0, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2022-10-28
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2022-10-29
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, NauseaAdult check-in
- 2022-10-31
- 2022-11-01
- 2022-11-02
- 2022-11-09
- 2022-11-18
- 2022-11-25
- 2022-11-30
- 2022-12-07
-
2023-01-25
Survey response — 3 months, dose 4MedDRA: Bacterial infection, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Poor · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-05-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-18 | Pfizer-BioNTech | |
| 3 | 2021-10-26 | Pfizer-BioNTech | No |
| 4 | 2022-10-26 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-20 | Unsuccessful |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Shoulder joint pain, night sweats
Systemic reaction (other): Symptoms began 29 hours after injection. Felt fine by 32 hours
Release 7 — 3 months, dose 2
Symptoms: Mild head cold. Runny nose, congestion, etc.
Release 9 — 6 months, dose 2
Symptoms: Pregnant, estimated due date of 1/16/22. 14 weeks at time of survey. Uneventful pregnancy thus far apart from severe nausea.
Release 10 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bacterial infection | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Night sweats | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ○ | ○ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release